336 related articles for article (PubMed ID: 33436160)
1. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
[TBL] [Abstract][Full Text] [Related]
2. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
Olson HE; Demarest ST; Pestana-Knight EM; Swanson LC; Iqbal S; Lal D; Leonard H; Cross JH; Devinsky O; Benke TA
Pediatr Neurol; 2019 Aug; 97():18-25. PubMed ID: 30928302
[TBL] [Abstract][Full Text] [Related]
4. Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.
Olson HE; Daniels CI; Haviland I; Swanson LC; Greene CA; Denny AMM; Demarest ST; Pestana-Knight E; Zhang X; Moosa AN; Fidell A; Weisenberg JL; Suter B; Fu C; Neul JL; Percy AK; Marsh ED; Benke TA; Poduri A
J Neurodev Disord; 2021 Sep; 13(1):40. PubMed ID: 34530725
[TBL] [Abstract][Full Text] [Related]
5. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H
Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011
[TBL] [Abstract][Full Text] [Related]
6. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
[TBL] [Abstract][Full Text] [Related]
7. First report of Tunisian patients with CDKL5-related encephalopathy.
Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F
Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975
[TBL] [Abstract][Full Text] [Related]
8. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
[TBL] [Abstract][Full Text] [Related]
9. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
[TBL] [Abstract][Full Text] [Related]
10. Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders.
Yan Y; He D; Wu J; Hou R; Sun K; Li L
Ital J Pediatr; 2020 Feb; 46(1):27. PubMed ID: 32111237
[TBL] [Abstract][Full Text] [Related]
11. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy.
Müller A; Helbig I; Jansen C; Bast T; Guerrini R; Jähn J; Muhle H; Auvin S; Korenke GC; Philip S; Keimer R; Striano P; Wolf NI; Püst B; Thiels Ch; Fogarasi A; Waltz S; Kurlemann G; Kovacevic-Preradovic T; Ceulemans B; Schmitt B; Philippi H; Tarquinio D; Buerki S; von Stülpnagel C; Kluger G
Eur J Paediatr Neurol; 2016 Jan; 20(1):147-51. PubMed ID: 26387070
[TBL] [Abstract][Full Text] [Related]
13. Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency disorder: Findings from a multicenter cohort.
Aledo-Serrano Á; Gómez-Iglesias P; Toledano R; Garcia-Peñas JJ; Garcia-Morales I; Anciones C; Soto-Insuga V; Benke TA; Del Pino I; Gil-Nagel A
Epilepsy Behav; 2021 May; 118():107946. PubMed ID: 33848848
[TBL] [Abstract][Full Text] [Related]
14. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
Amin S; Møller RS; Aledo-Serrano A; Arzimanoglou A; Bager P; Jóźwiak S; Kluger GJ; López-Cabeza S; Nabbout R; Partridge CA; Schubert-Bast S; Specchio N; Kälviäinen R
Epilepsia Open; 2024 Jun; 9(3):832-849. PubMed ID: 38450883
[TBL] [Abstract][Full Text] [Related]
15. New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy.
Melikishvili G; Epitashvili N; Tabatadze N; Chikvinidze G; Dulac O; Bienvenu T; Gataullina S
Epilepsy Behav; 2019 May; 94():308-311. PubMed ID: 30898514
[TBL] [Abstract][Full Text] [Related]
16. AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder.
Yennawar M; White RS; Jensen FE
J Neurosci; 2019 Jun; 39(24):4814-4828. PubMed ID: 30952813
[TBL] [Abstract][Full Text] [Related]
17. CDKL5 deficiency disorder: clinical features, diagnosis, and management.
Leonard H; Downs J; Benke TA; Swanson L; Olson H; Demarest S
Lancet Neurol; 2022 Jun; 21(6):563-576. PubMed ID: 35483386
[TBL] [Abstract][Full Text] [Related]
18. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
Wilmshurst JM; Gaillard WD; Vinayan KP; Tsuchida TN; Plouin P; Van Bogaert P; Carrizosa J; Elia M; Craiu D; Jovic NJ; Nordli D; Hirtz D; Wong V; Glauser T; Mizrahi EM; Cross JH
Epilepsia; 2015 Aug; 56(8):1185-97. PubMed ID: 26122601
[TBL] [Abstract][Full Text] [Related]
19. Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.
Fehr S; Wong K; Chin R; Williams S; de Klerk N; Forbes D; Krishnaraj R; Christodoulou J; Downs J; Leonard H
Neurology; 2016 Nov; 87(21):2206-2213. PubMed ID: 27770071
[TBL] [Abstract][Full Text] [Related]
20. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
Hong W; Haviland I; Pestana-Knight E; Weisenberg JL; Demarest S; Marsh ED; Olson HE
CNS Drugs; 2022 Jun; 36(6):591-604. PubMed ID: 35633486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
